Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07833176 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparative Efficacy of Amoxicillin, Metronidazole, and Chlorhexidine in Preventing Alveolar Osteitis

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 7 months later Feb 25, 2027 → Sep 25, 2027
See other at-risk trials from Khyber Medical University Peshawar

Record History

  1. Primary completion pushed from Feb 25, 2027 to Sep 25, 2027
    • Study completion pushed from Apr 20, 2027 to Oct 20, 2027
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will compare the effectiveness of amoxicillin, metronidazole, and chlorhexidine in preventing alveolar osteitis (dry socket) following lower third molar extraction. Participants will be randomly assigned to one of three groups: amoxicillin, metronidazole, or chlorhexidine. Participants will be assessed on Days 3 and 7 after extraction for the presence or absence of alveolar osteitis and postoperative pain. The study will determine whether there is a difference in the incidence of alveolar osteitis among the three treatment groups.
Trial Details
NCT Number NCT07833176
Lead Sponsor Khyber Medical University Peshawar
Collaborators: Khyber College of dentistry
Conditions
(from sponsor)		 Alveolar Osteitis
Related terms Dry Socket, Postoperative Pain
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov